REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Medikona (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Medikona Profile Updated: January 01, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Medikona is an enterprise based in Lithuania. Its main office is in Kaunas. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 04, 1996. 14 (2025) employees currently work for UAB Medikona. In its most recent financial highlights, the company reported a net sales revenue increase of 9.03% in 2024. UAB Medikona’s net profit margin decreased by 1.27% in 2024.

Headquarters
Karmelavos sen. Martinavos k. Martinavos g. 8
Kaunas; Kaunas County; Postal Code: LT-54475

Contact Details: Purchase the UAB Medikona report to view the information.

Website: http://www.medikona.lt

Basic Information
Total Employees:
Purchase the UAB Medikona report to view the information.
Registered Capital:
Purchase the UAB Medikona report to view the information.
Financial Auditors:
Purchase the UAB Medikona report to view the information.
Incorporation Date:
July 04, 1996
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Medikona report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.03%
Total operating revenue
9.03%
Net Profit (Loss) for the Period
-55.94%
Total equity
-32.08%
Net Profit Margin
-1.27%
Return on Equity (ROE)
-3.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?